A Study of Nipocalimab in Reducing the Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)
Clinical trial NCT06449651 · RECRUITING
Trial details
- NCT number
- NCT06449651
- Sponsor
- Janssen Research & Development, LLC
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-11
- Primary completion
- 2029-12-05
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.